
|Articles|July 12, 2004
New glaucoma drug offers convenient once-daily dosing
The FDA recently approved timolol (Istalol, ISTA Pharmaceuticals) ophthalmic solution 0.5% for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The product will be available within the next several months.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
2
White House Announces Action to Increase Competition, Decrease Cost of Biosimilar Development
3
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
4
FDA Approves Mirikizumab as Once Monthly Injection for Moderately to Severely Active Ulcerative Colitis
5


























































































































































